Breaking
•Far from fringe: How Israel’s mainstream parties vote with the far right•Which countries and players have won the most Ballon d’Or awards?•OpenAI says its agents turned off own safeguards•Anthropic posts $80bn loss in first half of 2026: WSJ•Tiger Shroff firing: How secret weapon delivery and a phone call exposed the shooters’ escape route•What are the deal contours of India-New Zealand FTA?•No frills, the true Avadi story•World headed for warming of 2.8C, UN reports, and US emissions rise•Nscale boss seeks to reassure staff amid AI market jitters•'I've waited 34 years for this' - Viking's 'special' story•Pakistan arrests man hunted by US over $126m postage fraud case•Nazi-looted Kandinsky returned to Jewish heirs sells for £31.56m•Taxman caps SBI retiree’s leave exemption at Rs 3 lakh; but ITAT grants full relief•76ers win opening game with LeBron James and Jaylen Brown, beating NBA champion Knicks 106-100 - WPXI•Breaking: Moon Officials Receive Suspended Sentences in Fishermen Repatriation Case - 조선일보•Early voting opens in Wisconsin, amid strong Minnesota turnout - Northern News Now•George Washington Bridge shooting: Male shot on upper level - ABC7 New York•Measles case tied to Ohio County hospital visit prompts exposure calls - WTOV•Temba Bavuma's Big Sachin Tendulkar Remark After Match-Defining 179 Against Australia - NDTV Sports•South Africa Australia Cricket - Herald and News•Far from fringe: How Israel’s mainstream parties vote with the far right•Which countries and players have won the most Ballon d’Or awards?•OpenAI says its agents turned off own safeguards•Anthropic posts $80bn loss in first half of 2026: WSJ•Tiger Shroff firing: How secret weapon delivery and a phone call exposed the shooters’ escape route•What are the deal contours of India-New Zealand FTA?•No frills, the true Avadi story•World headed for warming of 2.8C, UN reports, and US emissions rise•Nscale boss seeks to reassure staff amid AI market jitters•'I've waited 34 years for this' - Viking's 'special' story•Pakistan arrests man hunted by US over $126m postage fraud case•Nazi-looted Kandinsky returned to Jewish heirs sells for £31.56m•Taxman caps SBI retiree’s leave exemption at Rs 3 lakh; but ITAT grants full relief•76ers win opening game with LeBron James and Jaylen Brown, beating NBA champion Knicks 106-100 - WPXI•Breaking: Moon Officials Receive Suspended Sentences in Fishermen Repatriation Case - 조선일보•Early voting opens in Wisconsin, amid strong Minnesota turnout - Northern News Now•George Washington Bridge shooting: Male shot on upper level - ABC7 New York•Measles case tied to Ohio County hospital visit prompts exposure calls - WTOV•Temba Bavuma's Big Sachin Tendulkar Remark After Match-Defining 179 Against Australia - NDTV Sports•South Africa Australia Cricket - Herald and News
TheNewsPulse.pro
Home/clinical trials/diseases/drugs
clinical_trials

STAT+: Roche continues to look to China for new drugs

Confidence88·multiple reportsImportance90NP-EVT-20261020-658B8CE

China's Hansoh Pharmaceutical Group has announced that it struck a massive deal with Roche to develop a portfolio of antibody-drug conjugates.

Read the original at the primary source
STAT+: Roche continues to look to China for new drugs
Elaine Chen and Jonathan Wosen · 10/20/2026, 4:42:06 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse

Discussion

ChatsPulse · 0 threads

No discussion yet. Sign in and start the first thread —